期刊文献+

MR增强参数预测乳腺癌新辅助化疗疗效的前瞻性研究 被引量:4

Prospective study of the predictive value of MR dynamic parameters for the effect of breast cancer neoadjuvant chemotherapy
下载PDF
导出
摘要 目的:探讨乳腺癌新辅助化疗(NAC)后MR多期动态增强参数用于预测NAC疗效的价值。方法:应用3.0T MR对90例经NAC治疗后的浸润性乳腺癌患者行乳腺扫描。采用病灶兴趣区(ROI)高值法和手绘ROI法绘制病灶时间-信号强度曲线(TIC),记录TIC各相关参数值。采用t检验比较组织学显著反应(MHR)组和组织学非显著反应(NMHR)组NAC后乳腺癌病灶各参数的差异。以术后病理MHR者为阳性,绘制受试者工作特征(ROC)曲线,探讨MR多期动态增强参数预测MHR的最佳临界值。结果:乳腺癌NAC后不同MP术后评级组,两种ROI测量方法测得的病灶第二期强化程度(SI2%)、峰值强化程度(SIpeak%)、最大线性斜率(Smax)参数均有显著差异,MHR组参数值低于NMHR组(P<0.001)。由ROC曲线下面积可得ROI高值法对乳腺癌NAC后手术病理分级的预测能力略优于ROI手绘法。ROI高值法预测MHR的最佳临界值分别为SI2%=83%、SIpeak%=229.45%、Smax=404.995。结论:NAC后乳腺癌病灶采用ROI高值法和手绘法测得的MR多期动态增强参数,均可预测新辅助化疗疗效,ROI高值法优于ROI手绘法。 Objective:To investigate the predictive value of the dynamic contrast enhanced MR parameters on neoad- juvant chemotherapy (NAC) of breast cancer. Methods: Ninety patients with invasive breast cancer underwent 3.0T MR scans after NAC but before the surgery. Dynamic parameters of time-signal intensity curve (TIC) were recorded for region of interest (ROD ,which was measured by the high value method and the freehand method. Dynamic parameters measured after NAC were compared between the major histological response (MHR) group and non major histological response (NMHR) group using t test. Receiver operating characteristic (ROC) curve was used to define the optimal cutoff for the prediction of MHR for different dynamic parameters of MR. Results:For different MP groups of breast cancer after NAC, significant differences were found for the signal enhancement value at second phase (SI2%), the maximum enhancement val- ue of TIC (SIpcak%),and the maximum steepest slope (Smax) by both ROI measurement methods (P〈0. 001). Parameters of the MHR group were lower than that of NMHR group. According to the area under ROC curve, parameters measured by ROI high value method showed a better capability than that of the freehand method to predict the MP classification after NAC of breast cancer. The optimal cutoff values of SI2%,SIpeak% ,and S was 83%,229.45% and 404. 995 for ROI high value method,respectively. Conclusion: For breast cancer after NAC, dynamic parameters provided by both ROI measure- ment methods could be used to predict the effect of NAC. The ROI high value method showed a higher capability of predic- tion than the freehand method.
出处 《放射学实践》 2013年第6期647-650,共4页 Radiologic Practice
基金 "十一五"国家科技支撑计划课题(2007BAI05B05)
关键词 乳腺肿瘤 放化疗 辅助 治疗结果 磁共振成像 Breast neoplasms Chemoradiotherapy, adjuvant ~ Treatment outcome~ Magnetic resonance imaging
  • 相关文献

参考文献11

  • 1Chuthapisith S,EreminJM,Eremin O. Predicting response to neo adjuvant chemotherapy in breast cancer: molecular imaging. sys temic biomarkers and the cancer metabolome (Review)[J]. Oncol Rep,200S,20(4):699-703.
  • 2Weinstein S, Rosen M. Breast MR imaging: current indications and advanced imaging techniques[J]. Radiol Clin North Am. 2010,48 (S): 1013-1042.
  • 3Turnbull LW. Dynamic contrast-enhanced MRI in the diagnosis and management of breast cancer[J]. NMR Biomed , 2009. 22( 1 ) : 2S-39.
  • 4Martincich L, Montemurro F, De Rosa G, et al. Monitoring re?sponse to primary chemotherapy in breast cancer using dynamic contrast-enhanced magnetic resonance imaging[J]. Breast Cancer Res Treat,2004,S3(l) :67-76.
  • 5Molleran V, Mahoney Me. The BI-RADS breast magnetic rcso?nance imaging lexicon[J]. Magn Reson Imaging Clin N Am. 20 10. 18(2) :171-185.
  • 6Ah-See ML, Makris A, Taylor NJ, et al. Early changes in func?tional dynamic magnetic resonance imaging predict for pathologic response to neoadjuvant chemotherapy in primary breast cancer[J]. Clin Cancer Res,2008,14(20) :6580-6589.
  • 7Hillman GG, Singh-Gupta V, Al-Bashir AK. et al. Dynamic con?trast-enhanced magnetic resonance imaging of sunitinib-induced vascular changes to schedule chemotherapy in renal cell carcinoma xenograft tumors[J]. Transl Oncol,2010,3(5) :293-306.
  • 8Kuhl CK,Mielcareck P,Klaschik Sv et al. Dynamic breast MR im?aging: are signal intensity time course data useful for differential diagnosis of enhancing lesions?[J]. Radiology, 1999,211 ( 1): 101-110.
  • 9Le-Petross HC, Hylton N. Role of breast MR imaging in neoadju vant chemotherapy[J]. Magn Reson Imaging Clin N Am, 20 1 O. 18 (2) : 249-258.
  • 10Heywang-Kobrunner SH. Bick U, Bradley WG, et al. Interna?tional investigation of breast MRI: results of a multicentre study (11 sites) concerning diagnostic parameters for contrast-en hanced MRI based on 519 histopathologically correlated lesions[J]. Eur Radiol , 2001, 11C 1) : 531-546.

二级参考文献19

  • 1刘勇,汤光宇,顾伟中.动态增强MRI对乳腺癌血管生成的评价[J].国外医学(临床放射学分册),2005,28(6):413-416. 被引量:12
  • 2Carriero A, Ambrossini R, Mattei PA, et al.Magnetic resonance of the breast: correlation between enhancement patterns and microvessel density in malignant tumors.J Exp Clin Cancer Res, 2002,21 (3 Suppl) :83-87.
  • 3Byrnes K, White S, Chu Q, et al. High eIF4E, VEGF, and mierovessel density in stage Ⅰ to Ⅲ breast cancer. Ann Surg, 2006,243:684-692.
  • 4Oshida K, Nagashima T, UedaT, et al. Pharmacokinetic analysis of ductal carcinoma in situ of the breast using dynamic MR mammography. Eur Radiol,2005,15 : 1353-1360.
  • 5Weidner N, Semple JP, Welch WR, et al. Tumor angiogenesis and metastasis:correlation in invasive breast carcinoma. N Engl J Med, 1991,324 : 1-8,
  • 6Mattern J, Koomagi R, Volm M. Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumour cell proliferation in human epidermoid lung carcinoma.Br J Cancer, 1996,73:931-934.
  • 7Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med, 1971,285:1182-1186.
  • 8Gasparini G. Prognostic value of vascular endothelial growth factor in breast cancer. Oncologist, 2000,5 ( Suppl 11 ) :37-44.
  • 9Stomper PC, Winston JS, Herman S, et al, Angiogenesis and dynamic MR imaging gadolinium enhancement of malignant and benign breast lesions, Breast Cancer Res Treat,1997, 45:39-46.
  • 10Teifke A , Behr O, Schmidt M, et al. Dynamic MR imaging of breast lesions: correlation with microvessel distribution pattern and histologic characteristics of prognosis, Radiology, 2006, 239: 351-360.

共引文献16

同被引文献47

  • 1胡文娟,张蓓,潘玉林,谢蕴,刘维燕.磁共振灌注成像对局部进展期乳腺癌新辅助化疗疗效的评价[J].放射学实践,2011,26(1):25-29. 被引量:18
  • 2Pistolese C A, Perretta T, Cossu E, et al. Value of the correct diagnostic pathway through conventional imaging (mammography and ultrasound) in evaluating breast disease [J]. Radiol Med, 2011, 116(4): 584-594.
  • 3Medeiros L R, Duarte'C S, Rosa D D, et al. Accuracy of magnet- ic resonance in suspicious breast lesions: a systematic quantitative review and meta-analysis[J]. Breast Cancer Res Treat, 2011, 126 (2): 273-285.
  • 4Englander S A, Ulug A M, Brem R, et al. Diffusion imaging of human breast[J]. NMR Biomed, 1997, 10(7) : 348-352.
  • 5Matsumoto Y, Kuroda M, Matsuya R, et al. In vitro experimen- tal study of the relationship between the apparent diffusion coeffi- cient and changes in cellularity and cell morphology[J]. Oncol Rep, 2009, 22(3): 641-648.
  • 6Liu X, Zhou L, Peng W, et al. Effect of intravenous gadolinium- DTPA on diffusion-weighted imaging for prostate lesions and nor- mal tissue at 3.0-Tesla magnetic resonance imaging[J]. Acta Ra- diol, 2011, 52(5): 575-580.
  • 7Yuen S, Yamada K, Goto M, et al. Microperfusion induced ele vation of ADC is suppressed after contrast in breast carcinoma [J]. J MagnResonImaging, 2009, 29(5): 1080-1084.
  • 8Yamada K, Kubota H, Kizu O, et al. Effect of intravenous gad- olinium-DTPA on diffusion-weighted images evaluation of nor- mal brain and infarets[J]. Stroke, 2002, 33(7) : 1799-1802.
  • 9Wang C L, Chea Y W, Boll D T, et al. Effect of gadolinium chelate contrast agents on diffusion weighted MR imaging of the liver, spleen, pancreas and kidney at 3 T[J]. Eur J Radiol, 2011, 80(2): e1-7.
  • 10Firat A K, Sanli B, Karakas H M, et al. The effect of intrave- nous gadolinium-DTPA on diffusion-weighted imaging[J]. Neu- roradiology, 2006, 48(7): 465-470.

引证文献4

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部